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The decreased efficiency of immune responses in older people is partly a consequence of alterations in T
lymphocyte functions caused by modifications in the early events of signal transduction. Several alterations in
the signaling pathways of T lymphocytes have been described in older humans and animals. A unifying cause
could be modifications in the physicochemical properties of the plasma membrane resulting from changes in
its lipid composition and the distribution and function of lipid rafts (LR). The latter serve to assemble the initial
components of the signaling cascade. Accumulating data suggest that the function of plasma membrane LR is
altered with aging; we hypothesize that this would significantly contribute to immune dysregulation. The role
of aging and cholesterol in LR functions in T lymphocytes is reviewed and discussed here.
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Aging is a complex and multifactorial process. One of
the outcomes of aging is the appearance of numerous
diseases that are caused by alterations in different
physiological systems. These changes appear to occur
progressively throughout life and become more pro-
nounced with age. Alterations in the homeostatic status
of the body with aging decrease its capacity to cope with
daily challenges, resulting in an increased, overall level
of physiological stress and a greater demand on bodily
reserves. The immune system is particularly affected
by the process of aging [1], especially regarding the
numbers and functions of T lymphocytes. Studies of
older humans and animals have revealed that the most
noticeably altered T cell functions are the production of
IL-2 and the clonal expansion of effector and memory T
cells [2]. These functions are the outcome of the activa-
tion of T cells and it can be hypothesized that defects or
alterations in the proximal events of T cell activation will
strongly affect the efficiency of the immune response. In* Correspondence: tamas.fulop@usherbrooke.ca
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reproduction in any medium, provided the orother words, appropriate signal transduction cascades
trigger a response, but changes in the early events of
T cell signaling will result in less effective, altered overall
responses [3,4]. The antigen-presenting cell (APC)-
dependent major histocompatibility-restricted activation
of T cells requires an intimate communication between
APC and T cells by way of the formation of an immune
synapse [5,6]. It is now generally accepted that the for-
mation of the immune synapse could play an important
role in the assembly of the complex machinery of T cell
signal transduction which occurs in specialized micro-
clusters of the plasma membrane of the cell [5,7]. These
microdomains are resistant to detergent solubilization at
4°C and have been designated “detergent-resistant
plasma membrane domains” or “lipid rafts” (LR) [8].
This article will discuss the alterations in T cell signaling
with aging in relation to LR functions and the role of
cholesterol in this phenomenon.What is Immunosenescence?
As life expectancy of the populations of industrialized
nations continues to increase, the emergence of many dis-
eases associated with aging has become a major medical
and economic concern. For instance, the incidence of
infections, cancers and chronic inflammatory diseases
such as atherosclerosis and neurodegenerative diseasestd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and cost-related problem [9]. Although the underlying
causes relating aging to increased pathologies is not fully
understood, it is recognized that alterations of the im-
mune system play an important role [10]. The immune
system is a complex interactive system composed of many
different cells and cell subpopulations that are altered with
age, but not all to the same extent, and thus do not con-
tribute equally to immunosenescence. This should be con-
ceptualized as dysregulation of a system constantly trying
to adapt and to maintain homeostasis in the face of inputs
and outputs which are still only crudely defined [11]. Al-
though numerous studies on age-related immune altera-
tions have been published, the conclusions remain
controversial due to differences including those between
species and the lack of a definition of physiological aging.
Furthermore, the exclusion of some latent disease states,
nutritional, genetic and environmental differences add to
the complexity of understanding the mechanisms of the
physiological changes and their overall contributions to
aging [12]. However, the direct clinical consequences of
decreased immune responses with aging seem quite clear.
These are revealed by the increased incidence and severity
of infections, cancers and autoimmune disorders [10,13]
and can be related to the hallmark of immunosenescence
which is altered T cell function with aging [14]. Additional
changes in immune system components have been
described, but they are much less marked and may often
be secondary to changes in T cells. The changes include
not only the T cell-dependent B cell responses, but also
innate components sensitive to T cell feedback, especially
APC [15]. Although age-related changes in the immune
response are multifactorial, it is reasonable to assume that
an alteration in T lymphocyte activation is a central issue
in age-related modifications of the immune response.
Changes in T lymphocyte activation with aging
T cell signaling via T cell receptor and CD28
T cells are activated by antigen presented by APC [16].
The most efficient APC are dendritic cells, although
monocytes/macrophages and B cells are also able to
present antigens. APC presentation within the context
of major histocompatibility restriction triggers a cascade
of signaling events in naive T cells that culminates in the
activation of a set of genes resulting in the synthesis and
secretion of IL-2 and many other cytokines and factors
(Figure 1). In addition, activated T cells initiate immune
responses and traverse differentiation pathways resulting
in the development of different T cell subsets, according
to the priming conditions [17] regulated by the cytokines
and chemokines secreted in the immediate vicinity [7].
A universal requirement for any T cell response is
marked proliferation to accomplish clonal expansion
that is critical for generating T cells in sufficientnumbers to eliminate the antigen. Memory T cells pos-
sess different stimulatory requirements than naïve T
cells, but the efficiency of both naïve and memory cell
responses is diminished with age.
The primary receptor for T cell activation is the T cell
receptor (TCR) which delivers “signal 1”. However, this
is not sufficient for full T cell activation and, to avoid an-
ergy, T cells must receive a second signal delivered by a
plethora of co-receptors [17]. A number of these have
been described [16] but, functionally, the most import-
ant of these seems to be CD28 which, by recognizing
CD80 and CD86 ligands on APC, delivers “signal 2”
(Figure 1) that is essential to sustain T cell activation
[18]. In addition to its activity as a co-stimulatory
molecule, CD28 is involved in re-expression of the TCR,
recruitment and stabilization of T cell LR to the immune
synapse and the activation of plasma membrane lipid
metabolism through upregulation of the PI-3 K signaling
pathway [19,20]. Furthermore, CD28 co-stimulation
synergizes with TCR activation and induces IL-2, IL-4,
IL-5, TNF and granulocyte-macrophage colony stimulat-
ing factor (GM-CSF) production via NF-kB activation
[19,21]. More co-stimulation is required for the activa-
tion of naïve cells than for memory cells. It is now well
established that CD28 expression is decreased with aging
in CD8+ and CD4+ lymphocytes with a bias towards a
greater effect on CD8+ T cells [22].
Age-related alterations in T cell signaling
There are several age-associated alterations in these T
cell activation pathways, as observed in experimental
animals [23,24] and humans [2]. The most important
changes occur in CD4+ T cells resulting in the decreased
production of IL-2 and clonal expansion [3]. Although
there are no changes in TCR number at the cell surface,
the number of CD28 co-stimulatory molecules decreases
with aging [25]. Due to the essential role of CD28 to
prevent T cell anergy, the decrease in number of this
receptor could affect T cell responses in aged humans.
Nearly all the activity of the signaling pathways asso-
ciated with TCR activation or IL-2 receptor response
have been found to be altered with aging [26]. There is
an alteration in the early steps of T cell activation in-
cluding protein tyrosine phosphorylation, calcium
mobilization and the translocation of protein kinase C to
the plasma membrane. In addition, subsequent steps of
the signaling pathways including the Raf-Ras-MAP kin-
ase pathway are impaired. The decline in proximal and
intermediate events of transmembrane signaling leads to
the decreased activity of transcription factors, especially
NF-kB and NF-AT [27] and results in altered production
of cytokines with aging in T cells. This has been
observed in the case of T helper-1-dependent cytokines














Figure 1 Signal 1 and 2 during T cell activation. Upon antigen presentation by professional antigen presenting cells (APC), multiple
stimulatory molecules control full activation of T cells. Signal 1 is delivered by CD4/CD8 and T cell receptor (TCR)/major histocompatibility (MHC)
interaction while signal 2 is delivered by CD28/B7 interaction (or other co-stimulator-receptor pairs) The two signals together are required to
induce IL-2 production which will have autocrine and paracrine effects.
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Lately it became evident that one of the most important
changes underlying altered TCR signaling is at the level
of the Lck pathway (Figure 2A). Lck is at center stage of
TCR signaling initiation [29]. Phosphorylation of the
TCR by Lck initiates downstream signaling by creating
binding sites that recruit the cytosolic kinase ZAP70
(Zeta-chain-associated protein kinase 70) to the cell
membrane [30]. Lck is regulated by the C-terminal Src
kinase (Csk) by transphosphorylation and by depho-
sphorylation by phosphatases. Lck cycles between an
unphosphorylated (primed state), active and inactive
states. The Lck C-terminal tyrosine Tyr505 is phos-
phorylated by Csk which allows the Lck C-terminus to
bind its own SH2 domain, which closes the molecule. In
contrast, the trans-autophosphorylation of Lck activation
loop Tyr394 activates the kinase activity via rearrange-
ments of the active site [31]. In resting cells equilibrium
probably exists between the Lck phosphorylated on vari-
ous Tyr sites resulting in various levels of kinase acti-
vity determined by the amount of Csk, CD45 and SHP-1
(Src homology 2 domain-containing protein tyrosine-
phosphatase 1) activities (Figure 2A). Reduced phosphat-
ase activity within a close contact zone of Lck results in
Lck activation by trans-autophosphorylation of Tyr394
[32]. However, it seems that some part of Lck is in an
active form in resting T cells where a decrease of phos-
phatase activity will induce the signaling cascade as well
as segregation in various membrane domains. Indeed, at
basal states, Lck partitions preferentially into LR com-
partments where active and inactive Lck forms co-existat different stoichiometry and interact with distinct
pools of CD4 and Csk [33]. Thus, modulation of phos-
phatase activities in the close contact zone is an essential
stage of TCR activation to release the already active Lck.
Furthermore, in resting lymphocytes, Fyn has been
shown to be the predominant Src-family tyrosine kinases
(SFK) responsible for PAG/Cbp (phosphoprotein asso-
ciated with GEMs/Csk-binding protein) phosphorylation
recruiting Csk to LR to regulate Lck activity [34]. Consist-
ent with this, strong TCR stimulation reduces constitutive
PAG phosphorylation, thus favoring the dissociation of
Csk, the main negative regulator of Lck activity. This is
believed to induce TCR signal transduction.
Nrf2 activation alteration with aging
Aging is characterized by an increased level of oxidative
stress. This also influences T cell activation. The mech-
anism of redox-dependent regulation of signaling
pathways implies that receptor-mediated generation of
reactive oxygen species (ROS) influences the balance
between protein tyrosine kinase and phosphatase activ-
ities. Protein tyrosine kinases and phosphatases are
redox-sensitive targets with an oxidation-sensitive active
site cystein [37]. During receptor stimulation the transi-
ent increase of ROS may inactivate SHP-1 and thus
facilitate TCR signaling (Figure 2A). However, in a setting
where there is a constant increase in ROS, as in aging,
SHP-1 regulation is altered and a negative regulatory role
is favored in both the resting state and under stimulation.
Another important constituent of the activation process is
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Figure 2 Lck is a central node in the T cell receptor signaling pathway. (A) Following T cell receptor (TCR)/CD3 complex ligation, Lck
phosphorylation sites (inhibitory Tyr505 and activatory Tyr394) regulate Lck activity. The phosphorylation of immunotyrosine-based activating
motifs (ITAMs) by Lck induces recruitment of other kinases and leads to T cell activation. Phosphorylation of Lck is regulated positively by CD45
and negatively by C-terminal Src kinase (Csk), itself regulated by phosphoprotein associated with GEMs (PAG), and Src homology 2 domain-
containing protein tyrosine-phosphatase 1 (SHP-1). The regulation of phosphatases such as SHP-1 is strongly influenced by oxidative stress
(reactive oxygen species) and the Nrf2 pathway. (B) Nrf2 quantification in resting and activated (anti-CD3/CD28) T cell cytoplasm in young versus
older individuals is shown (a representative blot is shown). In addition, there are other regulatory mechanisms that function rapidly as negative
feedback loops from the TCR signalosome itself [19]. One of these involves phosphatases, especially SHP-1 [35]. Reduction of SHP-1 activity upon
stimulation lowers the threshold for TCR activation. It seems that under weak stimulation activated Lck associates with and phosphorylates SHP-1,
the activity of which then becomes reduced, but not sufficiently to allow full signaling to occur. Thus, under strong stimulation, Lck activity
would increase or become sufficient when SHP-1 activity is reduced very early in the signaling cascade. In turn, when the signal weakens, SHP-1
activity increases and consequently downregulates Lck activity [36]. Many other negative feedback mechanisms are in operation during the early
and late phases of TCR signaling [19].
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(Nrf2), a transcription factor [37]. Nrf2 is widely
expressed in different cells and tissues, and is activated by
oxidative and electrophilic stimulating agents, including
ROS. Nrf2 modulates antioxidant gene expression by
interacting with antioxidant response element. Nrf2 is
tethered to the suppressor protein Kelch-like ECH-asso-
ciated protein 1 in the cytoplasm under conditions of low
oxidative stress, and is degraded by the ubiquitin-
proteasome pathway. Under oxidative stress, the complexdissociates, and Nrf2 translocates to the nucleus and
enhances the expression of Nrf2/antioxidant response
element-associated antioxidant genes [38]. Our own pre-
liminary results suggest that Nrf2 is decreased upon
stimulation of T cells from young individuals, indicating
an increase of oxidative stress, while in the older people
no changes in the Nrf2 levels were detected. This suggests
a constantly increased ROS level, which is probably com-
pensated for by alternative mechanisms inhibiting the
translocation of Nrf2 into the nucleus (Figure 2B). This
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demonstrated in T cells by the decrease of reduced gluta-
thione and increase of oxidized glutathione levels [39].
Thus, with aging, increased oxidative stress together with
the changes of tyrosine kinase and phosphatase activities,
and their altered localization in the LR, contribute to
altered T cell signaling with aging.
Role of lipid rafts in T cell signaling
Studies in model lipid bilayers have established that they
can exist in an ordered (lo) gel-like phase and a disor-
dered (ld) phase. In the case of the cell plasma mem-
brane, the presence of cholesterol that associates with
sphingolipids and other lipids allows the formation of
microdomains in an lo-like fluid phase that floats within
the rest of the lipid bilayer, which is in the ld phase. The
term “lipid rafts” (LR) has been coined to designate these
(lo) microdomains [40,41]. LR are dynamic structures
that are generally thought to be small, submicroscopic
regions depleted of unsaturated phospholipids but
enriched in cholesterol, alkyl chain-saturated sphingoli-
pids and some lipid-anchored proteins [42]. Of signifi-
cance, studies with lymphocytes have revealed that LR
allow the recruitment of signaling proteins [43,44]. The
coalescence of LR, dubbed “lipid rafting”, is essential for
the formation of the immune synapse and signal trans-
duction in T cells [45]. However, this view was chal-
lenged by data from new imaging techniques such that
conceptualization of the nature and function of LR is
evolving [46-48]. Thus, LR are now considered as actual
structures occupying spaces in the membrane as fluctu-
ating dynamic nanoscale assemblies of sphingolipids,
cholesterol and proteins that can be stabilized into plat-
forms important for signaling and membrane trafficking.
They can be further clustered into a second state by spe-
cific lipid-lipid, protein-lipid and protein-protein inter-
actions [48] to generate more stable, selective and
functional platforms. The merger of specific nanoscale
rafts into larger and more stable platforms represents
the functionalization of specific rafts in membrane traf-
ficking as well as in signal transduction. For these events
to occur the protein and lipid composition needs to be
strictly fine tuned.
TCR are activated in microclusters subsequently trans-
ported to the locus of APC contact by actin filaments,
generating a so-called central supramolecular activation
cluster in which many TCRs are already dephosphory-
lated and inactive [49]. These data questioned the role of
immune synapses in the signal transduction process, but
helped to establish different roles for their components.
This also helped to reconceptualize the composition and
role of LR. Since then, modern high resolution imaging
revealed the existence of complexes with up to 7 to 20
TCRs, manifested as protein islands 70 to 140 nm indiameter [50]. Were the resting states of raft proteins
associated with nanoscale assemblies of raft lipids (for
example, sphingolipids and cholesterol), such variances
in size would result from the ability of these dynamic
structures to coalesce. Stabilization of fluctuating nano-
scale structures could facilitate increased access to Lck
to mediate TCR signaling [33,51]. In this setting,
how proteins and lipids (mainly cholesterol) interact
remains an important question. How does the lipid con-
text around the TCRs change the inactive to the acti-
vated state?
Role of cholesterol
The role of LR in T cell signaling has been challenged
recently [47,48] despite substantial evidence in favor of
their involvement in this process [46]. Several studies
concluded that LR are indeed involved in T cell signaling
because of the effects of acute cholesterol depletion - for
example, both aggregation of plasma membrane LR and
an increase in their numbers in the plasma membrane
were noted on partial cholesterol depletion. This pre-
ceded Src family kinase activation, leading to increased
co-localization between signaling molecules and result-
ing in an early T cell signaling response accompanied by
marked actin polymerization in the plasma membrane
[52]. It was also found that the kinase inhibitor PP2 did
not prevent LR aggregation, which is in line with micro-
cluster formation preceding T cell signaling [53]. The
quantity of cholesterol extracted from the membrane
can have differential effects on signal transduction,
emphasizing that the lipid-protein interaction is as
important as the protein-protein interaction in the sig-
naling process.
Cholesterol is known to increase the thickness of lipid
bilayers, as well as their stiffness. Both of these para-
meters are very important for interaction with mem-
brane proteins. A series of investigations in the late
1980s had already suggested that biochemical and bio-
physical alterations at the level of the cell plasma mem-
brane could be associated with the altered immune
response with aging in mice [54,55]. It was noted that
there were modifications with aging in the composition
of the lymphocyte cell plasma membrane lipids as well
as its fluidity. Earlier data from our laboratories have
shown that the levels of plasma membrane cholesterol,
the major stabilizing component of LR, were increased
two-fold in T lymphocytes of older individuals, resulting
in a plasma membrane that was less fluid than in T cells
from young individuals [26]. We hypothesized that these
observations had bearing on the events of T cell activa-
tion with aging. We investigated whether there were
alterations in the proximal events of T cell activation up-
stream of the signaling cascade or at the very early
events of signaling. We had used HPLC, thin layer
Fulop et al. Longevity & Healthspan 2012, 1:6 Page 6 of 9
http://www.longevityandhealthspan.com/content/1/1/6chromatography and other lipid detecting techniques to
show that there were marked changes in plasma mem-
brane composition (fatty acids, phospholipids) in T cells
of middle-aged normolipemic subjects [56]. We put for-
ward the hypothesis that these changes could be related
to the decreased T cell functions associated with immu-
nosenescence. We attempted to modulate the levels
of plasma membrane cholesterol in T cells from older
subjects in vitro to determine whether this manipulation
re-established efficient T cell signaling/functions. Initial
experiments using the cholesterol sequestrating com-
pound methyl β-cyclodextrin (MBCD) did not yield
results expected on the basis of the hypothesis men-
tioned above. It was observed that, besides decreasing
plasma membrane cholesterol, MBCD had an independ-
ent signal-disrupting activity. We therefore also used
inhibitors of cholesterol synthesis (lovastatin) in Jurkat
T cells. In this case, significantly reduced cell growth and
induced apoptosis at high concentrations were observed,
in agreement with the fact that only a few studies have
demonstrated the immunomodulatory role of statins in
human T cells [57]. Reciprocally, we attempted to “age”
T cells of young subjects by increasing the cholesterol
content to the levels found in T cells of older subjects.
This led to a decreased proliferative response as well as
IL-2 secretion, suggesting that homeostatic concentra-
tions of plasma membrane cholesterol are important for
T cell activation (Figure 3). An attractive approach
in vivo might therefore be to use high-density lipopro-
tein (HDL) as a physiologic means to extract cholesterol
by the so-called reverse transport cholesterol mechanism.
HDL particles or ApoA-I interact with cells to promote
the efflux of cholesterol via binding to specific transpor-
























Figure 3 Impact of lipid factors on T cell function. Proliferation
was measured after T cell activation with CD3/CD28 antibodies.
Peripheral blood mononuclear cells (PBMC) from young and older
people were treated with 5 mM methyl β-cyclodextrin (MBCD) for
30 minutes to extract membrane cholesterol prior to culturing.
*P <0.01.ABCG1 induces cholesterol efflux to HDL particles [59].
HDL preferentially interacts with LR and depletes chol-
esterol from these microdomains [60]. By this extraction
effect, HDL may modulate the signaling and the func-
tions of T cells. More work is needed to determine the
exact role of cholesterol and HDL in the altered activa-
tion of T cells with aging.
There are no well documented molecular mechanisms
to account for increased plasma membrane cholesterol
content in T cells of normolipemic older subjects. How-
ever, a dysregulation of cholesterol uptake involving the
low-density lipoprotein receptor, an increase in the
synthesis of cholesterol resulting from upregulation of
HMG-CoA reductase activity, an alteration in the activ-
ity of the ACAT enzyme or a deficiency in HDL-
dependent reverse cholesterol transport are all possible
causes. Further studies of cholesterol metabolism in T
cells and the modulation of the cholesterol content of
the plasma membrane are needed to shed light on the
alterations and the functional changes of LR and the
early events of T cell activation with aging.
Alterations in lipid raft functions with aging
LR move across the plasma membrane lipid bilayer as
discrete complexes to assemble the signalosome [61]
prior or concomitantly to the formation of the immune
synapse. LR clustering may depend on GM1 (monosialo-
tetrahexosylganglioside), GM3 and flotillin-1 [62] as well
as reorganization of the cytoskeleton. Whereas some of
the signaling components are constitutive parts of LR
(Lck, Cbp/PAG), others are recruited during activation
(TCR, CD28, IL-2 receptor, LAT, PI-3 K). We were the
first group to report a study of LR alterations in older
humans with aging [63]. We have shown that LR are dis-
tributed homogeneously in T cells of young subjects,
whereas we observed a different LR pattern and coales-
cence in the quiescent state in T cells of older subjects
[26]. These observations may reflect, to some extent,
low-grade activation with aging as part of the “Inflamm-
Aging” model [64]. We have also reported an alteration
in the function of LR with aging. Using confocal micros-
copy, we have shown that LR coalescence is altered with
aging in T cells activated by a combination of anti-TCR
and anti-CD28 antibodies. LR poorly coalesced in CD4+
T cells of older subjects [22] although the alterations
were less pronounced in the case of CD8+ T cells. Fur-
thermore, we have reported alterations in the recruit-
ment and activation of Lck and LAT into LR of T cells
from older humans [26]. One important finding was that
CD28 and the IL-2 receptor were weakly recruited to LR
in CD4+ T cells of older subjects. In contrast, these pro-
teins were already located in LR in CD8+ T cells from
older subjects prior to stimulation. These observations
suggested that the assembly of the signaling machinery
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assembly of the signalosome may be present in CD8+
T lymphocytes, as proposed by us [22] and by others
[65,66]. Currently we do not know why this alteration of
the plasma membrane occurs with aging. An intrinsic
alteration of cholesterol metabolism in older subjects
could contribute to these lipid changes [67]. Therefore,
an alteration in the plasma membrane composition of
T cells with aging seems to play a fundamental role in
their decreased functions as observed in immunosenes-
cence. Moreover, an alteration of the cytoskeleton in
T cells with aging can further contribute to altered sig-
naling via altered LR functions.Conclusions
Increasing numbers of older individuals not only in
industrialized nations represents major social and med-
ical challenges. Concomitantly, the incidence of age-
related diseases, many of which are influenced by the
dysregulation of the immune system, is increasing. There
is a large corpus of experimental data suggesting that
the immune response, mainly the T cell response, is
dysregulated in aging. The causes of this dysregulation
remain largely unknown, although evidence for altera-
tions in T cell receptor and CD28 co-receptor signaling
is widely accepted. One unifying cause for these altera-
tions could involve the initial events of signal transduc-
tion and the role of the plasma membrane. The novel
concept that the plasma membrane is composed of pri-
vileged signal transduction microdomains (LR) that cre-
ate a functional dynamic environment to assemble the
signalosome and the constitution of the immune synapse
provides a working framework to address the molecular
mechanisms of immunosenescence. Changes in the lipid
composition of the plasma membrane, especially in LR,
can be envisaged as a key event that adversely affects T
lymphocyte signaling in older subjects. These functional
changes may have serious clinical consequences such as
increased infections, cancers, autoimmune diseases and
thus poor quality of life. According to one estimate,
more than 50 pathologies have been associated with dys-
functional LR [68]. The inter-individual susceptibility to
the diseases of aging may be the cause or the conse-
quence of the differential changes in the immune
response (which is associated with T cell pool compos-
ition). It is of fundamental importance to understand the
role of LR to be able to intervene more precisely during
the evolution of diseases affecting older people. New im-
aging techniques should be applied to the study of sig-
naling events in T cells of healthy older subjects [46,47].
These studies could lead to the elaboration of new inter-
vention tools in the management of the physiological as
well as the pathological process of aging.Data from our laboratories and others have provided a
basis to pursue studies to understand the molecular
mechanisms of T cell signaling deficiencies associated
with aging, the involvement of LR, the formation of the
immune synapse and the assembly of the signaling ma-
chinery. Moreover, investigating T lymphocyte choles-
terol metabolism will help to understand the increase of
cholesterol content in the membrane. The role of free
radicals should also be assessed in connection with anti-
oxidant defense. Thus, a better understanding of immu-
nosenescence by intensive research and the development
of new methods and strategies to intervene in its evolu-
tion are essential for improving the quality of life of an
increasingly larger older population.
Abbreviations
ABC: ATP-binding cassette; APC: antigen-presenting cell; Cbp: Csk-binding
protein; Csk: C-terminal Src kinase; HDL: high-density lipoprotein; HPLC: high
performance liquid chromatography; IL: interleukin; LR: lipid rafts;
MBCD: methyl β-cyclodextrin; Nrf2: nuclear factor erythroid 2-related factor-2;
PAG: phosphoprotein associated with GEMs; ROS: reactive oxygen species;
SHP-1: Src homology 2 domain-containing protein tyrosine-phosphatase 1;
TCR: T cell receptor; TNF: tumor necrosis factor; ZAP70: Zeta-chain-associated
protein kinase 70.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
All authors contributed to writing the manuscript. All authors read and
approved the final manuscript.
Acknowledgements
This work was partly supported by grants from the Canadian Institutes of
Health Research (CIHR) (No106634, 106701), from the Université de
Sherbrooke and from the Research Center on Aging. The technical assistance
of Mrs Louise Rochon is gratefully recognized.
Author details
1Department of Medicine, Research Center on Aging, Graduate Program in
Immunology, Faculty of Medicine and Health Sciences, University of
Sherbrooke, 3001 12th Avenue North, Sherbrooke, Qc J1H 5N4, Canada.
2Department of Biochemistry, Graduate Program in Immunology, Faculty of
Medicine and Health Sciences, University of Sherbrooke, 3001 12th Avenue
North, Sherbrooke, Qc J1H 5N4, Canada. 3Center for Medical Research,
Tübingen Aging and Tumor Immunology Group, University of Tübingen,
Waldhörnlestrasse 22, Tübingen D-72072, Germany. 4Singapore Immunology
Network (SIgN), Immunos Building/Biopolis, Agency for Science Technology
and Research (A*STAR), 8A Biomedical Grove, Singapore 138648, Singapore.
5Research Center on Aging, University of Sherbrooke, 1036, rue Belvedere
Sud, Sherbrooke, Qc J1H 4C4, Canada.
Received: 7 June 2012 Accepted: 13 July 2012
Published: 4 October 2012
References
1. Agarwal S, Busse PJ: Innate and adaptive immunosenescence. Ann Allergy
Asthma Immunol 2010, 104:183–190.
2. Fulop T, Larbi A, Wikby A, Mocchegiani E, Hirokawa K, Pawelec G:
Dysregulation of T-cell function in the elderly: scientific basis and clinical
implications. Drugs Aging 2005, 22:589–603.
3. Schoenborn JR, Tan YX, Zhang C, Shokat KM, Weiss A: Feedback circuits
monitor and adjust basal Lck-dependent events in T cell receptor
signaling. Sci Signal 2011, 4(190):ra59.
4. Larbi A, Pawelec G, Wong SC, Goldeck D, Tai JJ, Fulop T: Impact of age on
T cell signaling: a general defect or specific alterations? Ageing Res Rev
2011, 10:370–378.
Fulop et al. Longevity & Healthspan 2012, 1:6 Page 8 of 9
http://www.longevityandhealthspan.com/content/1/1/65. Alarcón B, Mestre D, Martínez-Martín N: The immunological synapse: a
cause or consequence of T-cell receptor triggering? Immunology 2011,
133:420–425.
6. Reichardt P, Dornbach B, Gunzer M: APC, T cells, and the immune
synapse. Curr Top Microbiol Immunol 2010, 340:229–249.
7. Rodríguez-Fernández JL, Riol-Blanco L, Delgado-Martín C: What is an
immunological synapse? Microbes Infect 2010, 12:438–445.
8. Manes S, Viola A: Lipid rafts in lymphocyte activation and migration.
Mol Membr Biol 2006, 23:59–69.
9. Wick G, Jansen-Dürr P, Berger P, Blasko I, Grubeck-Loebenstein B: Diseases
of aging. Vaccine 2000, 18:1567–1583.
10. Meyer KC: Aging. Proc Am Thorac Soc 2005, 2:433–439.
11. Pawelec G: Immunosenescence and human longevity. Biogerontol 2003,
4:167–170.
12. Ligthart GH: The SENIEUR protocol after 16 years: the next step is to
study the interaction of ageing and disease. Mech Ageing Dev 2001,
122:136–140.
13. Fulop T, Larbi A, Kotb R, de Angelis F, Pawelec G: Aging, immunity, and
cancer. Discov Med 2011, 11:537–550.
14. Vasto S, Malavolta M, Pawelec G: Age and immunity. Immun Ageing 2006,
3:2.
15. Solana R, Tarazona R, Gayoso I, Lesur O, Dupuis G, Fulop T: Innate
immunosenescence: effect of aging on cells and receptors of the innate
immune system in humans. Semin Immunol 2012, [Epub ahead of print].
16. Smith-Garvin JE, Koretzky GA, Jordan MS: T cell activation. Annu Rev
Immunol 2009, 27:591–619.
17. Nel AE, Slaughter N: T-cell activation through the antigen receptor. Part 2:
role of signaling cascades in T-cell differentiation, anergy, immune
senescence, and development of immunotherapy. J Allergy Clin Immunol
2002, 109:901–915.
18. Riley JL, June CH: The CD28 family: a T-cell rheostat for therapeutic
control of T-cell activation. Blood 2005, 105:13–21.
19. Bjørgo E, Taskén K: Novel mechanism of signaling by CD28. Immunol Lett
2010, 129:1–6.
20. Tavano R, Gri G, Molon B, Marinari B, Rudd CE, Tuosto L, Viola A: CD28 and
lipid rafts coordinate recruitment of Lck to the immunological synapse
of human T lymphocytes. J Immunol 2004, 173:5392–5397.
21. Wang D, Matsumoto R, You Y, Che T, Lin XY, Gaffen SL, Lin X: CD3/CD28
costimulation-induced NF-kappaB activation is mediated by recruitment
of protein kinase C-theta, Bcl10, and IkappaB kinase beta to the
immunological synapse through CARMA1. Mol Cell Biol 2004, 24:164–171.
22. Larbi A, Dupuis G, Khalil A, Douziech N, Fortin C, Fulop T Jr: Differential role
of lipid rafts in the functions of CD4+ and CD8+ human T lymphocytes
with aging. Cell Signal 2006, 18:1017–1030.
23. Sadighi Akha AA, Miller RA: Signal transduction in the aging immune
system. Curr Opin Immunol 2005, 17:486–491.
24. Garcia GG, Miller RA: Age-related defects in CD4+ T cell activation
reversed by glycoprotein endopeptidase. Eur J Immunol 2003,
33:3464–3472.
25. Vallejo AN, Brandes JC, Weyand CM, Goronzy JJ: Modulation of CD28
expression: distinct regulatory pathways during activation and
replicative senescence. J Immunol 1999, 162:6572–6579.
26. Larbi A, Douziech N, Dupuis G, Khalil A, Pelletier H, Guerard KP, Fülöp T:
Age-associated alterations in the recruitment of signal-transduction
proteins to lipid rafts in human T lymphocytes. J Leukoc Biol 2004,
75:373–381.
27. Ponnappan U, Trebilcock GU, Zheng MZ: Studies into the effect of
tyrosine phosphatase inhibitor phenylarsine oxide on NFkappaB
activation in T lymphocytes during aging: evidence for altered IkappaB-
alpha phosphorylation and degradation. Exp Gerontol 1999, 34:95–107.
28. Rink L, Cakman I, Kirchner H: Altered cytokine production in the elderly.
Mech Ageing Dev 1998, 102:199–209.
29. Acuto O, Di Bartolo V, Michel F: Tailoring T-cell receptor signals by
proximal negative feedback mechanisms. Nature Rev Immunol 2008,
8:699–712.
30. Iwashima M, Irving BA, van Oers NS, Chan AC, Weiss A: Sequential
interactions of the TCR with two distinct cytoplasmic tyrosine kinases.
Science 1994, 263:1136–1139.
31. Yamaguchi H, Hendrickson WA: Structural basis for activation of human
lymphocyte kinase Lck upon tyrosine phosphorylation. Nature 1996,
384:484–489.32. Burns CM, Sakaguchi K, Appella E, Ashwell JD: CD45 regulation of tyrosine
phosphorylation and enzyme activity of src family kinases. J Biol Chem
1994, 269:13594–13600.
33. Nika K, Soldani C, Salek M, Paster W, Gray A, Etzensperger R, Fugger L,
Polzella P, Cerundolo V, Dushek O, Höfer T, Viola A, Acuto O: Constitutively
active Lck kinase in T cells drives antigen receptor signal transduction.
Immunity 2010, 32:766–777.
34. Yasuda K, Nagafuku M, Shima T, Okada M, Yagi T, Yamada T, Minaki Y,
Kato A, Tani-Ichi S, Hamaoka T, Kosugi A: Cutting edge: Fyn is essential for
tyrosine phosphorylation of Csk-binding protein/phosphoprotein
associated with glycolipid-enriched microdomains in lipid rafts in resting
T cells. J Immunol 2002, 169:2813–2817.
35. Lorenz U: SHP-1 and SHP-2 in T cells: two phosphatases functioning at
many levels. Immunol Rev 2009, 228:342–359.
36. Barrett DM, Black SM, Todor H, Schmidt-Ullrich RK, Dawson KS,
Mikkelsen RB: Inhibition of protein-tyrosine phosphatases by mild
oxidative stresses is dependent on S-nitrosylation. J Biol Chem 2005,
280:14453–14461.
37. Li H, Wang F, Zhang L, Cao Y, Liu W, Hao J, Liu Q, Duan H: Modulation of
Nrf2 expression alters high glucose-induced oxidative stress and
antioxidant gene expression in mouse mesangial cells. Cell Signal 2011,
23:1625–1632.
38. McMahon M, Thomas N, Itoh K, Yamamoto M, Hayes JD: Dimerization of
substrate adaptors can facilitate cullin-mediated ubiquitylation of
proteins by a "tethering" mechanism: a two-site interaction model for
the Nrf2-Keap1 complex. J Biol Chem
2006, 281:24756–24768.
39. Larbi A, Cabreiro F, Zelba H, Marthandan S, Combet E, Friguet B,
Petropoulos I, Barnett Y, Pawelec G: Reduced oxygen tension results in
reduced human T cell proliferation and increased intracellular oxidative
damage and susceptibility to apoptosis upon activation. Free Radic Biol
Med 2010, 48:26–34.
40. Simons K, Ikonen E: Functional rafts in cell membranes. Nature 1997,
387:569–572.
41. Brown DA, London E: Functions of lipid rafts in biological membranes.
Annu Rev Cell Dev Biol 1998, 14:111–136.
42. Brown DA: Lipid rafts, detergent-resistant membranes, and raft targeting
signals. Physiology (Bethesda) 2006, 21:430–439.
43. Pizzo P, Viola A: Lipid rafts in lymphocyte activation. Microbes Infect 2004,
6:686–692.
44. Kabouridis PS: Lipid rafts in T cell receptor signalling. Mol Membr Biol
2006, 23:49–57.
45. Taner SB, Onfelt B, Pirinen NJ, McCann FE, Magee AI, Davis DM: Control of
immune responses by trafficking cell surface proteins, vesicles and
lipid rafts to and from the immunological synapse. Traffic 2004,
5:651–661.
46. Tolar P: Inside the microcluster: antigen receptor signalling viewed with
molecular imaging tools. Immunology 2011, 133:271–277.
47. Simons K, Gerl MJ: Revitalizing membrane rafts: new tools and insights.
Nature Rev Mol Cell Biol 2010, 11:688–699.
48. Simons K, Sampaio JL: Membrane organization and lipid rafts. Cold Spring
Harb Perspect Biol 2011, 3:a004697.
49. Kaizuka Y, Douglass AD, Varma R, Dustin ML, Vale RD: Mechanisms for
segregating T cell receptor and adhesion molecules during
immunological synapse formation in Jurkat T cells. Proc Natl Acad Sci
U S A 2007, 104:20296–20301.
50. Lillemeier BF, Mörtelmaier MA, Forstner MB, Huppa JB, Groves JT, Davis MM:
TCR and Lat are expressed on separate protein islands on T cell
membranes and concatenate during activation. Nat Immunol 2010,
11:90–96.
51. Irles C, Arias-Martinez J, Guzmán-Bárcenas J, Ortega A: Plasma membrane
subdomain partitioning of Lck in primary human T lymphocytes. Can J
Physiol Pharmacol 2010, 88:487–496.
52. Mahammad S, Dinic J, Adler J, Parmryd I: Limited cholesterol depletion
causes aggregation of plasma membrane lipid rafts inducing T cell
activation. Biochim Biophys Acta 2010, 1801:625–634.
53. Billadeau DD, Burkhardt JK: Regulation of cytoskeletal dynamics at the
immune synapse: new stars join the actin troupe. Traffic 2006,
7:1451–1460.
54. Maczek C, Bock G, Jurgens G, Schonitzer D, Dietrich H, Wick G:
Environmental influence on age-related changes of human lymphocyte
Fulop et al. Longevity & Healthspan 2012, 1:6 Page 9 of 9
http://www.longevityandhealthspan.com/content/1/1/6membrane viscosity using severe combined immunodeficiency mice as
an in vivo model. Exp Gerontol 1998, 33:485–498.
55. Huber LA, Xu QB, Jürgens G, Böck G, Bühler E, Gey KF, Schönitzer D, Traill
KN, Wick G: Correlation of lymphocyte lipid composition membrane
microviscosity and mitogen response in the aged. Eur J Immunol 1991,
21:2761–2765.
56. Seres I, Freyss-Beguin M, Mohacsi A, Kozlovsky B, Simon J, Devynck MA,
Fulop T Jr: Alteration of lymphocyte membrane phospholipids and
intracellular free calcium concentrations in hyperlipidemic subjects.
Atherosclerosis 1996, 121:175–183.
57. Fulop T, Dupuis G, Fortin C, Douziech N, Larbi A: T cell response in aging:
influence of cellular cholesterol modulation. Adv Exp Med Biol 2006,
584:157–169.
58. Ansell BJ, Watson KE, Fogelman AM, Navab M, Fonarow GC: High-density
lipoprotein function recent advances. J Am Coll Cardiol 2005,
46:1792–1798.
59. Wang N, Lan D, Chen W, Matsuura F, Tall A: ATP-binding cassette
transporters G1 and G4 mediate cellular cholesterol efflux to
high-density lipoproteins. Proc Natl Acad Sci U S A 2004, 101:9774–9779.
60. Yu BL, Wang SH, Peng DQ, Zhao SP: HDL and immunomodulation: an
emerging role of HDL against atherosclerosis. Immunol Cell Biol 2010,
88:285–290.
61. Cemerski S, Shaw A: Immune synapses in T-cell activation. Curr Opin
Immunol 2006, 18:298–304.
62. Douglass AD, Vale RD: Single-molecule microscopy reveals plasma
membrane microdomains created by protein-protein networks that
exclude or trap signaling molecules in T cells. Cell 2005, 121:937–950.
63. Fülöp T, Douziech N, Goulet AC, Desgeorges S, Linteau A, Lacombe G,
Dupuis G: Cyclodextrin modulation of T lymphocyte signal transduction
with aging. Mech Age Dev 2001, 122:1413–1430.
64. Larbi A, Dupuis G, Douziech N, Khalil A, Fulop T: Low-grade inflammation
with aging has consequences for T-lymphocyte signaling. Ann NY Acad
Sci 2004, 1030:125–133.
65. Kovacs B, Maus MV, Riley JL, Derimanov GS, Koretzky GA, June CH,
Finkel TH: Human CD8+ T cells do not require the polarization of lipid
rafts for activation and proliferation. Proc Natl Acad Sci USA 2002,
99:15006–15011.
66. de Mello Coelho V, Nguyen D, Giri B, Bunbury A, Schaffer E, Taub DD:
Quantitative differences in lipid raft components between murine
CD4+ and CD8+ T cells. BMC Immunol 2004, 5:2.
67. Simons K, Ikonen E: How cells handle cholesterol. Science 2000,
290:1721–1726.
68. Michel V, Bakovic M: Lipid rafts in health and disease. Biol Cell 2007,
99:129–140.
doi:10.1186/2046-2395-1-6
Cite this article as: Fulop et al.: Aging, immunosenescence and
membrane rafts: the lipid connection. Longevity & Healthspan 2012 1:6.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
